News

Study findings could help researchers better tailor their drug-delivery particles to specific types of cancer, or design new particles that take advantage of the biological features of particular types of cancer cells.

The decisions made by cells – such as whether to divide – are made based on both extracellular signals and signals from within the cell, according to new research.

A new link discovered between the Parkinson's disease-associated protein alpha-synuclein and inflammation could provide a target for new treatments.

Researchers have developed a new method for differentiating between T and B cells, in the form of a probe with high specificity for B cells.

Going to the doctor might make you want to cry, and according to a new study, doctors could someday put those tears to good use.

A study has mapped out how sensory interneurons form from stem cells, a key step in developing cell therapy to restore sensation in people with spinal cord injuries.

Researchers have developed a promising new non-opioid painkiller, potentially with fewer side effects compared to other potent painkillers, and a unique mode of action, potentially opening a new pipeline for the development of analgesic drugs.

Patient-derived organoids could help direct pancreatic cancer treatment strategy, as they can predict how the tumor will respond to chemotherapy before surgery.

A University of Minnesota Twin Cities team has, for the first time, developed a new tool to predict and customize the rate of a specific kind of DNA editing called “site-specific recombination.” The research paves the way for more personalized, efficient genetic and cell therapies for diseases such as diabetes and cancer.

Researchers have discovered a mechanism that may explain how immature human egg cells are able to survive for long periods of time without losing their reproductive capacity, by modifying their metabolism and switching to a cellular "standby mode".